< Back to results
 
Amyotrophic lateral sclerosis type 2, juvenile | Primary lateral sclerosis, juvenile | Spastic paralysis, infantile onset ascending (sequence analysis of ALS2 gene)
ALS2
Request Now


Methodology

NGS


Specimen Requirements


Descriptive Volume /
Concentration 1
Container Transport
temperature
Sample
viability (days) 2
DNA ≥ 100 µL [50 ng/µL] Eppendorf Safe-lock Room temp. n/a
Peripheral blood ≥ 3 mL EDTA Room temp. 5
1 When it is not possible to collect the minimum volume for the test, please contact CGC Genetics
2 Maximum shipping time to ensure sample quality

Turnaround Time (Days)

- 60

Specialties

- Rare diseases, Neurology / Neuropediatrics


CGC Reference

- 5721




Associated Tests


Hereditary spastic paraplegia (WES based NGS panel of 74 genes, including CNV analysis)
Amyotrophic lateral sclerosis/motor neuron disease (WES based NGS panel of 29 genes, including CNV analysis)